Skip to Primary Navigation

Skip to main content

FCA Healthcare roundup: Two cases of medically unnecessary products and services

Montage of various medical supplies and pills.
GRIP Montage: Getty Images

Kevin Kinsella

<1 min read
 Click to share on Facebook (Opens in new window/tab) Click to share on Twitter (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Our in-brief, biweekly roundup of notable DOJ False Claims Act cases related to healthcare fraud.

During the second half of February, the US DOJ announced two separate enforcement actions related to FCA violations. One case involves a scheme to refer patients for unnecessary healthcare services. The other is related to billing the US Department of Labor (DOL) millions of dollars in unnecessary prescription compound creams.

, , , , , , , , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial Sign in

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience